GROUP ONE TRADING LLC - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 49 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING LLC ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q2 2024$15,826
-8.6%
46,754
+52.5%
0.00%
Q1 2024$17,310
+163.7%
30,654
+27.5%
0.00%
Q4 2023$6,564
-66.2%
24,043
-75.2%
0.00%
Q3 2023$19,427
-96.4%
97,088
-40.3%
0.00%
-100.0%
Q1 2023$537,085
+1828.9%
162,753
+858.6%
0.00%
Q4 2022$27,844
-58.4%
16,978
-29.7%
0.00%
Q2 2022$67,000
-59.4%
24,134
-50.8%
0.00%
Q1 2022$165,000
-35.3%
49,097
-26.2%
0.00%
Q1 2021$255,000
-45.6%
66,512
-35.9%
0.00%
-100.0%
Q4 2020$469,000
+143.0%
103,738
+130.2%
0.00%0.0%
Q4 2019$193,000
-60.9%
45,059
-64.4%
0.00%
-75.0%
Q3 2019$493,000
+12.3%
126,459
+13.7%
0.00%0.0%
Q2 2019$439,000
+116.3%
111,245
+137.6%
0.00%
+100.0%
Q1 2019$203,000
+463.9%
46,823
+365.1%
0.00%
Q4 2018$36,000
+1100.0%
10,067
+1577.8%
0.00%
Q2 2017$3,000
-66.7%
600
-72.5%
0.00%
Q1 2017$9,000
-18.2%
2,180
-43.9%
0.00%
Q4 2015$11,000
+22.2%
3,8830.0%0.00%
Q3 2015$9,000
-43.8%
3,883
-11.4%
0.00%
Q2 2015$16,0004,3830.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 3,586$15,0000.01%
THOMPSON DAVIS & CO., INC. 1,500$6,0000.01%
Psagot Value Holdings Ltd. 39,115$166,0000.01%
GUARDIAN CAPITAL ADVISORS LP 10,000$41,0000.01%
Virtu KCG Holdings LLC 41,537$177,0000.01%
D'Orazio & Associates, Inc. 1,000$4,0000.00%
SIMPLEX TRADING, LLC 7,703$32,0000.00%
CITIGROUP INC 370$2,0000.00%
Advisor Group, Inc. 1,500$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 73,366$311,0000.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders